FDA Drug Low Class III Terminated

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial, packaged in a) 30-count (NDC 0487-0201-03), b) 60-count (NDC 0487-0201-60), Rx only, MFG: Nephron Pharma

Reported: June 15, 2022 Initiated: April 13, 2022 #D-1021-2022

Product Description

Reason for Recall

cGMP deviations: Temperature abuse

Details

Recalling Firm: Mckesson Medical-Surgical Inc. Corporate Office
Units Affected: 56 pouches
Distribution: USA nationwide.
Location: Richmond, VA

Frequently Asked Questions

What product was recalled? ▼

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial, packaged in a) 30-count (NDC 0487-0201-03), b) 60-count (NDC 0487-0201-60), Rx only, MFG: Nephron Pharma. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 56 pouches.

Why was this product recalled? ▼

cGMP deviations: Temperature abuse

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on June 15, 2022. Severity: Low. Recall number: D-1021-2022.